120 related articles for article (PubMed ID: 35543199)
1. Ambulatory pulse pressure and its contributors in autosomal dominant polycystic kidney disease.
Koska-Ścigała A; Jankowska M; Szyndler A; Narkiewicz K; Dębska-Ślizień A
Adv Clin Exp Med; 2022 May; 31(5):575-578. PubMed ID: 35543199
[TBL] [Abstract][Full Text] [Related]
2. Patterns of Kidney Function Decline in Autosomal Dominant Polycystic Kidney Disease: A Post Hoc Analysis From the HALT-PKD Trials.
Brosnahan GM; Abebe KZ; Moore CG; Rahbari-Oskoui FF; Bae KT; Grantham JJ; Schrier RW; Braun WE; Chapman AB; Flessner MF; Harris PC; Hogan MC; Perrone RD; Miskulin DC; Steinman TI; Torres VE;
Am J Kidney Dis; 2018 May; 71(5):666-676. PubMed ID: 29306517
[TBL] [Abstract][Full Text] [Related]
3. Prevalence of Hypertension in Children with Early-Stage ADPKD.
Massella L; Mekahli D; Paripović D; Prikhodina L; Godefroid N; Niemirska A; Ağbaş A; Kalicka K; Jankauskiene A; Mizerska-Wasiak M; Afonso AC; Salomon R; Deschênes G; Ariceta G; Özçakar ZB; Teixeira A; Duzova A; Harambat J; Seeman T; Hrčková G; Lungu AC; Papizh S; Peco-Antic A; De Rechter S; Giordano U; Kirchner M; Lutz T; Schaefer F; Devuyst O; Wühl E; Emma F
Clin J Am Soc Nephrol; 2018 Jun; 13(6):874-883. PubMed ID: 29674338
[TBL] [Abstract][Full Text] [Related]
4. Blood pressure and intracranial aneurysms in autosomal dominant polycystic kidney disease.
Niemczyk M; Pilecki T; Gradzik M; Bujko M; Niemczyk S; Pączek L
Kidney Blood Press Res; 2014; 39(6):630-5. PubMed ID: 25571876
[TBL] [Abstract][Full Text] [Related]
5. Health-related quality of life in patients with autosomal dominant polycystic kidney disease and CKD stages 1-4: a cross-sectional study.
Miskulin DC; Abebe KZ; Chapman AB; Perrone RD; Steinman TI; Torres VE; Bae KT; Braun W; Winklhofer FT; Hogan MC; Rahbari-Oskoui F; Moore CG; Flessner MF; Schrier RW;
Am J Kidney Dis; 2014 Feb; 63(2):214-26. PubMed ID: 24183837
[TBL] [Abstract][Full Text] [Related]
6. Tubular secretion of creatinine in autosomal dominant polycystic kidney disease: consequences for cross-sectional and longitudinal performance of kidney function estimating equations.
Spithoven EM; Meijer E; Boertien WE; Sinkeler SJ; Tent H; de Jong PE; Navis G; Gansevoort RT
Am J Kidney Dis; 2013 Sep; 62(3):531-40. PubMed ID: 23714171
[TBL] [Abstract][Full Text] [Related]
7. Urinary Angiotensinogen in addition to Imaging Classification in the Prediction of Renal Outcome in Autosomal Dominant Polycystic Kidney Disease.
Park HC; Kim J; Cho A; Kim DH; Lee YK; Ryu H; Kim H; Oh KH; Oh YK; Hwang YH; Lee KB; Kim SW; Kim YH; Lee J; Ahn C;
J Korean Med Sci; 2020 Jun; 35(22):e165. PubMed ID: 32508065
[TBL] [Abstract][Full Text] [Related]
8. Copeptin levels and kidney function in ADPKD: case-control study.
Corradi V; Martino F; Gastaldon F; Scalzotto E; Caprara C; Fortunato A; Pinaffo G; Marchetti C; Fabbi F; Giavarina D; Ferrari F; Rosner MH; Ronco C
Clin Nephrol; 2016 Sep; 86(9):147-53. PubMed ID: 27487355
[TBL] [Abstract][Full Text] [Related]
9. Kidney concentrating capacity in children with autosomal recessive polycystic kidney disease is linked to glomerular filtration and hypertension.
Seeman T; Bláhová K; Fencl F; Klaus R; Lange-Sperandio B; Hrčková G; Podracká Ĺ
Pediatr Nephrol; 2023 Jul; 38(7):2093-2100. PubMed ID: 36538056
[TBL] [Abstract][Full Text] [Related]
10. Left ventricular hypertrophy in a contemporary cohort of autosomal dominant polycystic kidney disease patients.
Chen H; Watnick T; Hong SN; Daly B; Li Y; Seliger SL
BMC Nephrol; 2019 Oct; 20(1):386. PubMed ID: 31653199
[TBL] [Abstract][Full Text] [Related]
11. Ambulatory blood pressure in hypertensive patients with autosomal dominant polycystic kidney disease.
Li Kam Wa TC; Macnicol AM; Watson ML
Nephrol Dial Transplant; 1997 Oct; 12(10):2075-80. PubMed ID: 9351068
[TBL] [Abstract][Full Text] [Related]
12. The association of endothelin-1 levels with renal survival in polycystic kidney disease patients.
Kocyigit I; Eroglu E; Kaynar AS; Kocer D; Kargi S; Zararsiz G; Bayramov R; Imamoglu H; Sipahioglu MH; Tokgoz B; Dundar M; Oymak O
J Nephrol; 2019 Feb; 32(1):83-91. PubMed ID: 30022320
[TBL] [Abstract][Full Text] [Related]
13. Fibulin Levels in Autosomal Dominant Polycystic Kidney Disease and Its Relationship to Arterial Stiffness.
Inci A; Akin O; Ellidag HY; Eren E; Dolu S; Sari F
Clin Lab; 2017 Nov; 63(11):1869-1874. PubMed ID: 29226648
[TBL] [Abstract][Full Text] [Related]
14. Relationship of urinary endothelin-1 with estimated glomerular filtration rate in autosomal dominant polycystic kidney disease: a pilot cross-sectional analysis.
Raina R; Lou L; Berger B; Vogt B; Do AS; Cunningham R; Vasavada P; Herrmann K; Dell K; Simonson M
BMC Nephrol; 2016 Feb; 17():22. PubMed ID: 26923419
[TBL] [Abstract][Full Text] [Related]
15. Early cardiovascular manifestations in children and adolescents with autosomal dominant polycystic kidney disease: a single center study.
Karava V; Benzouid C; Hogan J; Dossier C; Denjean AP; Deschênes G
Pediatr Nephrol; 2018 Sep; 33(9):1513-1521. PubMed ID: 29774463
[TBL] [Abstract][Full Text] [Related]
16. Tolvaptan in Japanese patients with later-stage autosomal dominant polycystic kidney disease.
Oguro M; Kogure Y; Hoshino J; Ubara Y; Mizuno H; Sekine A; Kawada M; Sumida K; Hiramatsu R; Hasegawa E; Yamanouchi M; Hayami N; Suwabe T; Sawa N; Takaichi K
J Nephrol; 2018 Dec; 31(6):961-966. PubMed ID: 30357715
[TBL] [Abstract][Full Text] [Related]
17. Peripheral augmentation index and vascular inflammation in autosomal dominant polycystic kidney disease.
Heffernan KS; Kuvin JT; Sarnak MJ; Perrone RD; Miskulin DC; Rudym D; Chandra P; Karas RH; Menon V
Nephrol Dial Transplant; 2011 Aug; 26(8):2515-21. PubMed ID: 21292815
[TBL] [Abstract][Full Text] [Related]
18. Mean platelet volume and its relation with arterial stiffness in patients with normotensive polycystic kidney disease.
Orscelik O; Kocyigit I; Akpek M; Dogdu O; Kaya C; Unal A; Sipahioglu M; Tokgoz B; Zengin H; Oymak O; Kaya MG
J Investig Med; 2013 Mar; 61(3):597-603. PubMed ID: 23360844
[TBL] [Abstract][Full Text] [Related]
19. RAPID-ADPKD (Retrospective epidemiological study of Asia-Pacific patients with rapId Disease progression of Autosomal Dominant Polycystic Kidney Disease): study protocol for a multinational, retrospective cohort study.
Ryu H; Park HC; Oh YK; Sangadi I; Wong A; Mei C; Ecder T; Wang AY; Kao TW; Huang JW; Rangan GK; Ahn C
BMJ Open; 2020 Feb; 10(2):e034103. PubMed ID: 32034027
[TBL] [Abstract][Full Text] [Related]
20. Sympathetic activity and blood pressure pattern in autosomal dominant polycystic kidney disease hypertensives.
Cerasola G; Vecchi M; Mulè G; Cottone S; Mangano MT; Andronico G; Contorno A; Parrino I; Renda F; Pavone G
Am J Nephrol; 1998; 18(5):391-8. PubMed ID: 9730562
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
